Tender Title: Supply of Pharmaceuticals
Reference Number: GEM/2025/B/6169771
Issuing Authority: Department of Military Affairs, Ministry of Defence
This tender involves the procurement of various pharmaceuticals under the Ministry of Defence. The scope of work includes the supply of critical medications including INJ NOVORAPID, TAB ATORVASTATIN 80 MG, TAB ISOSORBIDE DINITRATE HYDRALZINE 37.5 MG, and TAB PREGABALIN. The total quantity to be supplied is approximately 573,870 units of the aforementioned pharmaceuticals, catering to the specific needs of military personnel and related health services.
Scope of Work and Objectives
The primary objective of this tender is to ensure the continuous and timely availability of essential medications for military healthcare facilities. Vendors are required to demonstrate their capability in meeting the supply needs while adhering to the strict standards set by the Department of Military Affairs. As a part of the procurement process, the contractor will be responsible for quality assurance and compliance with the technical specifications outlined in the tender document.
Eligibility Criteria
To participate in this tender, suppliers must fulfill specific eligibility criteria which includes:
- Registration as a legal entity in the pharmaceutical domain.
- Proven experience in bulk supply of pharmaceuticals to government or military institutions.
- Compliance with national healthcare regulations and quality standards.
Technical Requirements
Vendors are expected to meet the following technical requirements:
- All pharmaceuticals must be sourced from approved manufacturers.
- Supplied products must conform to the standard specifications and quality certifications as per regulatory norms.
- Detailed documentation regarding the supply chain, storage conditions, and shelf life must be provided.
Financial Requirements
Participants must demonstrate their financial health through documentation such as:
- Recent financial statements.
- Bank solvency certificates.
- Pricing proposals that meet the budget constraints set by the issuing authority.
Document Submission Details
All submissions must adhere to the following guidelines:
- Complete tender submissions must be made in digital format via the designated procurement portal.
- It is imperative to provide all requested documents, including pricing, technical specifications, and compliance statements.
- Late submissions or incomplete documentation will lead to disqualification from the bid process.
Special Provisions
The tender offers benefits for Micro, Small, and Medium Enterprises (MSEs) and encourages startups in the pharmaceutical domain, promoting an inclusive procurement approach. Specific provisions outlined in the tender documentation will support the participation of eligible MSEs, including simplified qualification requirements and potential financial aids.
Evaluation Process
The evaluation of bids will occur in a structured manner, focusing on:
- Technical capability and compliance with pharmaceutical standards.
- Financial viability and pricing.
- Past performance and reliability in supply.
Delivery Locations
Suppliers must be prepared to deliver to designated military healthcare facilities, ensuring adherence to stipulated delivery timelines and logistics as specified in the tender.
Contact Information
For further inquiries regarding the tender, interested parties may need to refer directly to the Department of Military Affairs through their official channels for more precise contact details.
This tender encapsulates a critical procurement action aimed at ensuring the health and well-being of military personnel through the reliable supply of essential pharmaceuticals, fostering a cooperative business environment in the defense procurement landscape. All interested suppliers are encouraged to engage actively and submit their bids to contribute to this noble cause.
Tender BOQ Items
16 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements for this tender include being a registered entity in the pharmaceutical sector, demonstrating experience in supplying medications to government institutions, and fulfilling all necessary regulatory compliances. Interested bidders must also show valid certifications and a track record of quality assurance to qualify for participation.
Vendors must possess and provide evidence of essential certifications such as Good Manufacturing Practices (GMP), FDA (or relevant authority) approvals, and any other relevant compliance documents that validate the quality and safety of the pharmaceuticals. Documentation must showcase adherence to national and international standards.
Submissions for this tender must be conducted using the designated online procurement system, ensuring that all required documents are attached in accepted formats such as PDF or Word. Bidders should confirm the completeness of their submission to avoid disqualification due to incomplete information.
An Earnest Money Deposit (EMD) is required as part of the bidding process, which is a monetary assurance to confirm the bidder’s sincerity. Details regarding the amount and submission process are outlined in the tender documentation to guide prospective bidders.
There are significant benefits for Micro, Small, and Medium Enterprises (MSEs), including reduced eligibility criteria and potential financial support provided during the bidding and execution phases. This approach aims to encourage participation from smaller entities, fostering a diverse and competitive bidding environment in the pharmaceuticals supply chain.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders